Pivmecillinamwas approved by the FDA in 2024 as a first-line oral therapy for uncomplicated female urinary tract infections. Pivmecillinam is the metabolic precursor of mecillinam, a unique extended-spectrum β-lactam penicillin-based antibiotic, which has good activity against multidrug-resistant ...
P-1713. Impact of an Evidence-Based Order Panel on Antimicrobial Prescribing in Ambulatory Patients with Complicated and Uncomplicated Cystitisdoi:10.1093/ofid/ofae631.1879BACKGROUND. Optimizing antimicrobial prescribing for urinary tract infections (UTI) represents an area of opportunity for ambulatory ...
=-=(12, 15)-=-sCollege women have a high incidence of uncomplicated urinary tract infectionss(UTIs), and are frequently treated empirically. ... EK Min,US Ha,YH Cho - 《International Journal of Antimicrobial Agents》 被引量: 119发表: 2008年 Antimicrobial resistance in community-acquired urin...
AMR results were summarized for cUTI and UTIs (uncomplicated UTI [uUTI], mixed uUTI/cUTI, cUTI), as some studies reported a mixture of cUTI and uUTI, or UTI severity not specified. RESULTS. We included 44 US primary studies in UTI (13 cUTI, 31 all UTIs), with results summarized for...
The findings show a higher rate of quinolone resistance than those found in other studies conducted in Europe and the United States, which include community-acquired uncomplicated lower UTI, complicated lower UTI, and pyelonephritis, ranging between 23 and 31% [8,20,21,22,23]. The high ...